Skip to main content

Table 3 Cox regression analysis, overall survival (n = 560 in the multiple analysis)

From: The prognostic value of microRNA-126 and microvessel density in patients with stage II colon cancer: results from a population cohort

 

Simple analysis

Multiple analysis

 

HR

95% CI

p-value

HR

95% CI

p-value

Sex

      

Female

1

  

1

  

Male

1.41

1.08-1.84

0.01

1.68

1.28-2.19

0.0002

Age, median 74

      

<74

1

  

1

  

≥74

2.39

1.80-3.16

<0.0001

2.58

1.94-3.42

<0.0001

T category

      

T3

1

  

1

  

T4

1.99

1.43-2.78

0.0001

1.76

1.24-2.49

0.002

Malignancy grade

      

Medium + Low

1

     

High*

1.22

0.88-1.69

0.24

   

Localisation

      

Right

1

     

Left

0.96

0.73-1.24

0.74

   

Perforation

      

No

1

  

1

  

Yes

1.80

1.20-2.72

0.005

1.49

0.96-2.32

0.08

Fixation

      

No

1

  

1

  

Yes

1.60

1.17-2.18

0.004

1.26

0.89-1.78

0.20

Lymph nodes

      

≥12

1

     

<12

1.06

0.82-1.39

0.64

   

Neuronal invasion

      

No

1

     

Yes

1.19

0.76-1.87

0.44

   

Vascular invasion

      

No

1

  

1

  

Yes

1.60

1.12-2.30

0.01

1.47

1.02-2.11

0.04

MSI status

      

MSI

1

     

MSS

0.92

0.69-1.24

0.59

   

miRNA-126

      

<median

1

  

1

  

>median

0.75

0.57-0.98

0.03

0.76

0.58-1.00

0.051

MVD

      

<median

1

     

>median

1.01

0.77-1.32

0.94

   
  1. HR: hazard ratio; CI: confidence interval; MSI: microsatellite instability; MSS: microsatelite stable; miRNA-126: microRNA-126; MVD: microvessel density.
  2. *Including mucinous and sigillocellular adenocarcinomas.
  3. Significant p-values are highlighted in bold.